Xiang Liu - BlackRock Health Portfolio Mang
| BMEZ Stock | USD 15.42 0.15 0.98% |
Insider
Xiang Liu is Portfolio Mang of BlackRock Health Sciences
| Address | 50 Hudson Yards, New York, NY, United States, 10001 |
| Phone | 212 810 5300 |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Thomas Shenk | Pmv Pharmaceuticals | 77 | |
| Jinzi Wu | Ascletis Pharma | 60 | |
| Francesca MD | Candel Therapeutics | 46 | |
| Deepika PharmD | Pmv Pharmaceuticals | 47 | |
| Nancy Ruiz | Larimar Therapeutics | N/A | |
| MBA MD | Monopar Therapeutics | 38 | |
| Robert DeLuccia | Acurx Pharmaceuticals LLC | 78 | |
| Terence Kohler | Verrica Pharmaceuticals | N/A | |
| Gary MD | Verrica Pharmaceuticals | 47 | |
| Ileen Winick | Candel Therapeutics | N/A | |
| Anne McKay | Fennec Pharmaceuticals | 70 | |
| Leila MD | Pmv Pharmaceuticals | 61 | |
| George Hill | Ascletis Pharma | 72 | |
| FMEDSCI MD | Candel Therapeutics | 62 | |
| Ming CPA | Ascletis Pharma | N/A | |
| Handan He | Ascletis Pharma | 61 | |
| Mark Meier | Fennec Pharmaceuticals | N/A | |
| David Mack | Pmv Pharmaceuticals | 62 | |
| MD MS | Candel Therapeutics | 53 | |
| Inf MD | Candel Therapeutics | 64 | |
| Alexander MS | Fennec Pharmaceuticals | N/A | |
BlackRock Health Sciences Leadership Team
Elected by the shareholders, the BlackRock Health's board of directors comprises two types of representatives: BlackRock Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BlackRock. The board's role is to monitor BlackRock Health's management team and ensure that shareholders' interests are well served. BlackRock Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BlackRock Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Lee, Portfolio Mang | ||
| Xiang Liu, Portfolio Mang |
BlackRock Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BlackRock Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 106.51 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 26.48 % | ||||
| Number Of Shares Shorted | 479.22 K | ||||
| Price To Book | 0.84 X | ||||
| Price To Sales | 22.48 X | ||||
| Short Ratio | 0.89 X | ||||
| Earnings Per Share | 0.73 X | ||||
| Market Capitalization | 1.63 B | ||||
| Total Asset | 3.09 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Additional Tools for BlackRock Stock Analysis
When running BlackRock Health's price analysis, check to measure BlackRock Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Health is operating at the current time. Most of BlackRock Health's value examination focuses on studying past and present price action to predict the probability of BlackRock Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Health's price. Additionally, you may evaluate how the addition of BlackRock Health to your portfolios can decrease your overall portfolio volatility.